In the vast sea of publicly traded companies. Brisco assists management in separating themselves from the masses
We Provide Strategic Positioning
Filter out all of the capital markets’ noise and focus management in the right direction
Effective Business Execution + Investor Audience = Capital Gains
Investor Relations is never effective without the successful execution of management goals, but together in concert can equate to capital gains
Investor Relations has become a crucial tool in influencing the investment behavior of the capital markets.
Brisco Capital is an Investor Relations consultancy that acts as a bridge of communication between public equities and the investment community. Consistent communication of management’s goals and progress through face-to-face, collateral material, multi and social media or press releases, are all key elements in achieving fair equity value.
Investor Relations is a process by which several results can be achieved:
- Instant adoption of the story by which our audience becomes shareholders
- Mid term to latter adoption: Investment community members start watching the story and monitoring management progress with the ultimate goal of them becoming shareholders.
- No adoption: we find out why and work with management with this invaluable feedback
Trading today is as much about promoting your company as it is about stock share value. Our ultimate goal is to have investment community members replace one equity symbol with our clients. This will allow them to follow the progress of management milestones.
Here are some of our Brisco Capital clients…
Petro-Victory Energy Corp. is a very cohesive, organized seeker of hydrocarbon exploration and production project opportunities in Latin America, and a developer of its portfolio assets.
AnalytixInsight is the developer of proprietary technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight’s flagship product, CapitalCube, is a software-as-a-service (SAAS) platform providing high-quality financial research and analysis for investors, financial portals and media.
Aequus Pharmaceuticals Inc. is a Vancouver-based company, focused on enhancing delivery methods for approved drugs and select consumer products that are limited by non-compliance, high frequency dosing, first-pass metabolism side effects, painful injections, or where the commercial presentation can be improved by making a long acting alternative available.